9.11
-0.08
(-0.87%)
At close: January 31 at 8:16:34 AM GMT+1
Breakdown
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Total Assets
135,567.00
154,386.00
152,705.00
161,616.49
Total Liabilities Net Minority Interest
15,304.00
12,534.00
10,214.00
10,798.39
Total Equity Gross Minority Interest
120,263.00
141,852.00
142,491.00
150,818.10
Total Capitalization
120,263.00
141,852.00
142,491.00
150,818.10
Common Stock Equity
120,263.00
141,852.00
142,491.00
150,818.10
Net Tangible Assets
120,263.00
141,852.00
142,491.00
150,818.10
Working Capital
120,263.00
141,852.00
142,491.00
150,818.10
Invested Capital
120,263.00
141,852.00
142,491.00
150,818.10
Tangible Book Value
120,263.00
141,852.00
142,491.00
150,818.10
Share Issued
84,795.52
82,066.51
77,942.82
75,918.47
Ordinary Shares Number
84,795.52
82,066.51
77,942.82
75,918.47
9/30/2021 - 4/28/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
19X.SG Axsome Therapeutics Inc
102.25
-2.01%
I9SA.HA Verona Pharma PLC
55.00
+0.92%
TRRI Alzex Neuropharma Inc.
0.1980
0.00%
HALB Halberd Corporation
0.0034
+13.33%
RAPP Rapport Therapeutics, Inc.
16.41
-1.44%
ASND Ascendis Pharma A/S
130.66
+2.64%
NAMS NewAmsterdam Pharma Company N.V.
22.29
+2.39%
PCVX Vaxcyte, Inc.
88.32
-3.95%
DAWN Day One Biopharmaceuticals, Inc.
12.37
-3.81%
IBIO iBio, Inc.
3.0100
+1.35%